Zobrazeno 1 - 10
of 203
pro vyhledávání: '"W Lesslauer"'
Publikováno v:
The Journal of Immunology. 157:3178-3182
The role of TNF and its type 1 receptor (TNFR1) in the pathogenesis of collagen-induced arthritis (CIA) was investigated in mice using two approaches. First, DBA/1 mice were treated after immunization with type II collagen by injecting TNFR1-IgG1 fus
Autor:
William L. Castleman, Jean Nicolas Vauthey, U Ettlin, H Loetscher, Edward M. Copeland, B Wipf, Lyle L. Moldawer, S F Lowry, M B Welborn, W Lesslauer, K Van Zee, M. A. Rogy, Atsushi Kaibara, Jeffrey H. Pruitt, J S Kenney, Paul D. Edwards, D Stüber
Publikováno v:
The Journal of Experimental Medicine
Tumor necrosis factor (TNF) is a potentially useful adjunct to anticancer therapies. However, the clinical utility of TNF has been limited by generalized toxicity and hypotension. Recently, studies have begun to dissect the individual proinflammatory
Autor:
L.A.H. Monnens, N.C.A.J. van de Kar, Mario A. Vermeer, V.W.H. van Hinsbergh, W. Lesslauer, T. Kooistra
Publikováno v:
Blood, 85, 3, pp. 734-743
Blood, 85, 734-743
Blood, 85, 734-743
Infections with verocytotoxin (VT) producing Escherichia coli have been strongly implicated in the epidemic form of hemolytic uremic syndrome (HUS). Endothelial damage plays a central role in the pathogenesis of HUS. In vitro studies have shown that
Publikováno v:
The Journal of Immunology. 153:5274-5284
The role of the two TNF receptor types, TNF-R55 and TNF-R75, was studied on mouse fibroblasts, taking advantage of TNF-R55-deficient mice generated by gene targeting (Tnfr1 degree-mice), and selectivity of human TNF-alpha for mouse TNF-R55. Radioliga
Publikováno v:
Europe PubMed Central
Tumor necrosis factor alpha (TNF alpha) has previously been reported to have both inhibitory and stimulatory effects on hematopoietic progenitor cells. Specifically, TNF alpha has been proposed to stimulate early hematopoiesis in humans. In the prese
Autor:
Ricardo Díaz Martín, David L. Moyes, W Lesslauer, Jonathan Cohen, H Loetscher, Thomas J. Evans, A. Carpenter
Publikováno v:
The Journal of Experimental Medicine
The aim of this study was to compare the ability of both a 55- and 75-kD soluble tumor necrosis factor receptor immunoglobulin G fusion protein (sTNFR-IgG) in protecting against death in a murine model of gram-negative sepsis. Pretreatment with 250 m
Autor:
Walter Fiers, Wim Declercq, W Lesslauer, J. Grooten, Peter Vandenabeele, Dominique Vercammen, M Brockhaus, M. Van De Craen, H Loetscher
Publikováno v:
The Journal of Experimental Medicine
We investigated the biological role of the human tumor necrosis factor p75 (hTNF-R75), making use of the species specificity of TNF responses in murine (m) T cell lines. Several TNF-mediated activities on mouse T cells, such as cytokine induction or
Publikováno v:
The Journal of Immunology. 149:911-917
TNF is a highly pleiotropic cytokine. The recent identification of two distinct cellular receptors for TNF may provide explanations for the many different TNF activities. We have investigated the expression of the two receptor types, TNFR alpha (75 k
Publikováno v:
The Journal of Immunology. 146:3045-3048
In this study we investigated the expression of the 55 kDa (p55) and the 75 kDa (p75) TNF receptors in CD56+ NK cells and their role in NK and lymphokine-activated killer cells cell functions. By using mAb against the p55 and p75 TNF-R, NK cells were
Autor:
Terje Espevik, W Lesslauer, M R Shalaby, Anders Sundan, Hansruedi Loetscher, Manfred Brockhaus
Publikováno v:
The Journal of Experimental Medicine
The present study was undertaken to further characterize the interaction of monoclonal antibodies (mAbs) against tumor necrosis factor (TNF) receptors with different targets, and to assess their ability to influence TNF effects on U937 and human endo